Skip to main content

UKNFR Reports

April 2021

Report from Peter Kalu:

I am pleased to say that the latest United Kingdom National Flap Registry (UKNFR) update seems to suggest that reconstructive flap activity is returning to levels seen prior to the first UK national lockdown.  

As we all appreciate, COVID-19 has had a significant impact upon the number of flap cases performed and our attention is becoming increasingly focused on how we address the backlog. I’m hopeful that solutions and plans will be put in place to expand capacity so we see recorded case number exceed normal levels.

The UKNFR report for April 2021 is available here

 

February 2021

Report from Peter Kalu:

The latest United Kingdom National Flap Registry (UKNFR) update comes as we begin to look forward to Spring. 

The successful rollout of the COVID-19 vaccination programme during the midst of the third national lockdown should hopefully give some confidence to flap surgeons as they consider how to once again ‘unlock’ reconstructive services. 

This report shows evidence of the effects of a resurgent COVID-19 and the reconfiguration of healthcare services to deal with the unfolding medical emergency. 

The next report in April will be issued after we have past the one year mark since the first national lockdown began in March 2020. We shall then begin to issue summary details on the year-on-year activity since the emergence of COVID-19. 

The UKNFR February 2021 report available here.

 

December 2020

Report from Peter Kalu:

The UKNFR is likely to be a good barometer of surgical activity in the NHS. 

In October 2020 there were signs of a dramatic increase in reconstructive capacity. These gains were short-lived as registered case numbers rapidly tailed-off in November and December most likely due to the arrival of the second wave of COVID-19. We shall see what effect the annual round of ‘winter pressures’ has on further registry numbers.

The UKNFRDecember 2020 report is available here

 

October 2020

Report from Peter Kalu:

Since my last update in August, we have quite rapidly found ourselves in the midst of a second wave of COVID-19. For many units, this may prove to be a further unwelcome challenge for major reconstructive procedures. 

The UKNFR October 2020 report is available here.

 

August 2020

Report from Peter Kalu:

The nationally reported levelling-off in COVID case numbers is welcome news and has allowed minds to focus upon the restoration of reconstructive services. 

An expansion in flap reconstruction capacity is evidenced by an increase in UKNFR case numbers. I am hopeful that this trend will continue as we head into the autumn and that all opportunities are taken to address the inevitable backlog in cases.  

The report of UKNFR August 2020 is available here.

 

June 2020

Message from Peter Kalu:

I have now taken up post as the UKNFR Audit Lead from Anita - thank you for a wonderful handover and the last 5 years of service in making the UKNFR what it is today.

I know that COVID-19 has been particularly challenging to all flap surgeons on so many levels and I hope that over the coming weeks and months we see a steady resumption of surgical services. 

I would ask you all to encourage your fellow colleagues to see this as an opportunity to “build back better” and start to enter data into what is becoming an increasingly useful tool to demonstrate the utility of flap surgery In surgical care.

The report of UKNFR End of June 2020 is available here.

 

May 2020

Latest UKNFR Report - from Anita Hazari

The impact of Covid19

As expected with Covid19, the numbers have fallen significantly, as breast reconstruction was halted in March. The flaps currently being performed are for H&N oncology reconstruction (priority 2) and Lower/ upper limb trauma (priority 1).

Covid related data entries have also been added into UKNFR in the last few days, so we will get data regarding swab positivity prior to surgery, at discharge and development of Covid19 in the postopertaive period. This should help us to monitor if peri-operative outcomes are more adversely affected in the Covid negative and positive groups.

Full report available here.